Robert L. Duffy - 05 Mar 2025 Form 4 Insider Report for BWX Technologies, Inc. (BWXT)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
06 Mar 2025, 16:46:32 UTC
Prior SEC filing
04 Mar 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Robert L. Duffy by Theresa B. Taylor, attorney-in-fact

Key filing fact

Robert L. Duffy filed Form 4 for BWX Technologies, Inc. (BWXT) on 06 Mar 2025.

Key facts

  • This page summarizes Robert L. Duffy's Form 4 filing for BWX Technologies, Inc. (BWXT).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 06 Mar 2025, 16:46.

Change

  • Previous filing in this sequence was filed on 04 Mar 2025.
  • Current net transaction value: -$624,161.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BWXT transaction

Common Stock

Sale

Transaction value
$624,161
Shares
-6,000
Change %
-65%
Price
$104.03
Shares after
3,206
Date
05 Mar 2025
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The price in Column 4 is a weighted average price. The shares were sold at prices ranging from $104.0000 to $104.1200 inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .